Literature DB >> 23438686

Prognostic relevance of PCI-related myocardial infarction.

Pier Woudstra1, Maik J Grundeken, Tim P van de Hoef, Lars Wallentin, Keith A Fox, Robbert J de Winter, Peter Damman.   

Abstract

Procedure-related myocardial infarction (pMI) is directly associated with a coronary revascularization procedure, such as percutaneous coronary intervention (PCI) or CABG surgery. In contrast to spontaneous myocardial infarction (MI), the prognostic relevance of pMI is the subject of ongoing debate. Data from retrospective analyses of large, randomized clinical trials, and large, contemporary cohort studies have several shortcomings that limit their extrapolation to clinical practice. In our opinion, the currently available evidence is insufficient to conclude that pMI during PCI, as currently defined, always has important prognostic implications. Until further evidence is available, we recommend adopting the definition for MI given in the third universal definition of MI, which differentiates between pMI and spontaneous MI. This is important not only for clinical decision-making but also for the interpretation of pMI as a surrogate end point in clinical trials. Further studies are essential to understand the pathophysiology and consequences of pMI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23438686     DOI: 10.1038/nrcardio.2013.19

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  32 in total

Review 1.  Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.

Authors:  Girish Ganesha Babu; J Malcolm Walker; Derek M Yellon; Derek J Hausenloy
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

2.  Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction.

Authors:  Giuseppe De Luca; Nicolette Ernst; Arnoud W J van 't Hof; Jan Paul Ottervanger; Jan C A Hoorntje; A T Marcel Gosselink; Jan-Henk E Dambrink; Menko-Jan de Boer; Harry Suryapranata
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

3.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White
Journal:  Eur Heart J       Date:  2007-10       Impact factor: 29.983

Review 4.  Myocardial infarction due to percutaneous coronary intervention.

Authors:  Abhiram Prasad; Joerg Herrmann
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

5.  Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).

Authors:  Peter Damman; Lars Wallentin; Keith A A Fox; Fons Windhausen; Alexander Hirsch; Tim Clayton; Stuart J Pocock; Bo Lagerqvist; Jan G P Tijssen; Robbert J de Winter
Journal:  Circulation       Date:  2011-12-23       Impact factor: 29.690

6.  5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.

Authors:  Bo Lagerqvist; Steen Husted; Fredrik Kontny; Elisabeth Ståhle; Eva Swahn; Lars Wallentin
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

7.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome.

Authors:  Nicholas L Mills; Antonia M D Churchhouse; Kuan Ken Lee; Atul Anand; David Gamble; Anoop S V Shah; Elspeth Paterson; Margaret MacLeod; Catriona Graham; Simon Walker; Martin A Denvir; Keith A A Fox; David E Newby
Journal:  JAMA       Date:  2011-03-23       Impact factor: 56.272

8.  With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.

Authors:  Chris C S Lim; William J van Gaal; Luca Testa; Florim Cuculi; Jayanth R Arnold; Theodoros Karamitsos; Jane M Francis; Steffen E Petersen; Janet E Digby; Stephen Westaby; Charalambos Antoniades; Rajesh K Kharbanda; Louise M Burrell; Stefan Neubauer; Adrian P Banning
Journal:  J Am Coll Cardiol       Date:  2011-02-08       Impact factor: 24.094

9.  Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.

Authors:  Allen Jeremias; Donald S Baim; Kalon K L Ho; Manish Chauhan; Joseph P Carrozza; David J Cohen; Jeffrey J Popma; Richard E Kuntz; Donald E Cutlip
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

10.  Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.

Authors:  Abhiram Prasad; Charanjit S Rihal; Ryan J Lennon; Mandeep Singh; Allan S Jaffe; David R Holmes
Journal:  Circ Cardiovasc Interv       Date:  2008-08       Impact factor: 6.546

View more
  1 in total

1.  Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.

Authors:  Zhuoshan Huang; Xing Shui; Yesheng Ling; Linli Zhou; Wenqi Shi; Yanting Luo; Suhua Li; Jieming Zhu; Shujie Yu; Jinlai Liu
Journal:  Clin Cardiol       Date:  2020-12-02       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.